The estimated Net Worth of Robert F. Werner is at least $1.14 Milione dollars as of 6 September 2024. Mr. Werner owns over 240 units of Invitae Corp stock worth over $774 and over the last 4 years he sold NVTA stock worth over $1,137,519. In addition, he makes $0 as Chief Accounting Officer at Invitae Corp.
Robert has made over 18 trades of the Invitae Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 240 units of NVTA stock worth $9,398 on 6 September 2024.
The largest trade he's ever made was selling 21,559 units of Invitae Corp stock on 16 May 2023 worth over $25,871. On average, Robert trades about 2,687 units every 51 days since 2020. As of 6 September 2024 he still owns at least 38,724 units of Invitae Corp stock.
You can see the complete history of Mr. Werner stock trades at the bottom of the page.
Robert F. Werner serves as Chief Accounting Officer of the Company. He has served as the Company’s Corporate Controller from September 2017 through the effectiveness of his appointment as Chief Accounting Officer and Principal Accounting Officer. Prior to joining the Company, from February 2015 to September 2017, Mr. Werner served as Vice President of Finance and Corporate Controller of Proteus Digital Health, Inc., a digital medicine pharmaceuticals company. Prior to that, Mr. Werner served as Corporate Controller and Principal Accounting Officer of CardioDx, Inc., a molecular diagnostics company, from March 2012 to February 2015. Mr. Werner is a Certified Public Accountant and started his career at Ernst & Young LLP. Mr. Werner holds a Bachelor of Science in Accounting and a Master of Accountancy in Professional Accounting from Brigham Young University’s Marriott School of Management.
Robert Werner is 47, he's been the Chief Accounting Officer of Invitae Corp since 2020. There are 14 older and 4 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
Robert's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli... e James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
Invitae Corp executives and other stock owners filed with the SEC include: